Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight

Diabetes
N HariharanK Mookhtiar

Abstract

Glucokinase is the predominant hexokinase in pancreatic beta-cells and liver parenchymal cells and functions as a critical component of the glucose-sensing apparatus in these glucose-responsive cell types. In the beta-cells, the sensing leads to insulin secretion, while the role in hepatocytes is thought to be in hepatic glucose uptake. To determine the physiological response to an increase in hepatic glucokinase expression, transgenic mice expressing the human hepatic glucokinase gene under the control of a liver-specific human apolipoprotein A-I gene enhancer were generated. Transgenic mice had twofold higher total fasting hepatic glucokinase mRNA, which resulted in a modest 20% increase in fasting glucokinase activity. These animals showed lower fasting plasma glucose, insulin, and lactate levels and improved tolerance to glucose. In addition, glucokinase transgenic animals weighed less and had lower BMI than nontransgenic animals. Thus, glucokinase transgenic animals demonstrate that a modest change in hepatic glucokinase activity enhances the metabolism of glucose.

Citations

Dec 22, 1999·Genetic Analysis : Biomolecular Engineering·A KrasnovH Mölsä
Aug 25, 2012·Journal of Agricultural and Food Chemistry·An-Sheng ChengTsu-Liang Chang
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·D FarrellyN Hariharan
Sep 16, 2010·The Journal of Biological Chemistry·Susana RosJoan J Guinovart
Sep 21, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kuok Teong OngDouglas G Mashek
Jun 14, 2003·Current Opinion in Clinical Nutrition and Metabolic Care·Wolfgang Langhans
Aug 26, 1998·Annual Review of Nutrition·F BoschA Valera
Jan 31, 2008·Expert Opinion on Investigational Drugs·Matthew Coghlan, Brendan Leighton
Dec 7, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·Loranne Agius
May 4, 2004·Annales d'endocrinologie·C PosticJ Girard
May 4, 2011·Diabetes/metabolism Research and Reviews·Hongsoo JungJinwoo Choi
May 24, 2015·Molecular and Cellular Endocrinology·Danielle CamerXu-Feng Huang
Oct 18, 2014·Expert Opinion on Therapeutic Targets·Clarence HaleMurielle M Véniant
Mar 25, 2005·Biochemical Society Transactions·B LeightonM P Coghlan
Jan 5, 2002·The Journal of Biological Chemistry·Maria Veiga-da-Cunha, Emile Van Schaftingen
Sep 5, 1997·The Journal of Biological Chemistry·K D NiswenderM A Magnuson
Sep 16, 2016·Biology of Reproduction·Laura G GoetzHugh S Taylor
Jul 25, 2008·The Biochemical Journal·Loranne Agius
Feb 20, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jiri PetrakChristopher D Vulpe
Dec 9, 2004·American Journal of Physiology. Endocrinology and Metabolism·Loubna Erraji-BenchekrounClaudine André
Jan 1, 2008·The Journal of Biological Chemistry·Daniel CifuentesJoan J Guinovart

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Related Papers

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
A ValeraF Bosch
The American Journal of Physiology
M D Meglasson, F M Matschinsky
© 2021 Meta ULC. All rights reserved